Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK.
Alexander James ThompsonJi-Hee YounBruce GuthrieRobert HainsworthPeter T DonnanGabriel RogersDaniel MoralesKatherine PaynePublished in: BMJ open (2023)
Statins and bisphosphonates have a quantifiable DTD. The size of estimated disutilities suggest they are likely to be important for cost-effectiveness, particularly in individuals at low-risk when treated for primary prevention.